Evaluate: Yes, the patents hold enormous value. In addition, the DCVax-L trial data is worth a pretty sum as well. No one has that level of data that spans that amount of time.
It was difficult for me to value these assets in my enterprise value computation. At the end of the day you need to pick reasonable numbers and go with it for the purposes of YOUR investment objective.
People should take heed when Doc Logic said the investment was de-risked at data lock. Peace.
Wrong. I suggested nothing of the sort. In fact I said nothing regarding the market value of nwbo patents.
Those patents are on the books at nominal value, so there is nothing to write down in event of failure. Accounting value (as stated by nwbo) can be quite different from market value.